Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Omicron booster

- PMLiVE

UK’s MHRA reveals advertising lapses

Regulatory agency upholds complaints about iMed Systems, Genus and Lloyds

- PMLiVE

Three directors join UK’s MHRA

Valerie Beral, Alexander Markham and David Webb join UK regulatory body

DH names new chief executive of the MHRA

Ian Hudson to lead UK medicines regulator

- PMLiVE

Lilly’s Strattera wins new adult ADHD licence in UK

On course for wider EU approval for adults yet to receive treatment

- PMLiVE

Medical researcher jailed for faking trial data

MHRA completes first prosecution under Good Laboratory Practice Regulations

- PMLiVE

MHRA launches virtual ‘innovation office’

Aims to smooth regulatory pathway for companies developing novel medicines, devices or technology

- PMLiVE

Increase in unlicensed medicines sold in UK

MHRA says drugs from Eastern Europe finding their way to UK stores

- PMLiVE

MHRA campaign to revive GP, pharmacist and public reporting of side effects

Medicines watchdog to drive awareness of Yellow Card System

- PMLiVE

MHRA plays catch up with pharma on Twitter

UK regulator launches corporate account on the social network

- PMLiVE

MHRA streamlines POM-OTC reclassification rules

Aims to speed the process of switching drug status from prescription-only to over-the-counter

- PMLiVE

UK considers greater self-regulation of pharmacies

And MHRA to review sanctions and penalties

- PMLiVE

MHRA appoints Michael Rhodes as medical director of devices

He will take over from Dr Susanne Ludgate, who is retiring in December

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links